Ginkgo Bioworks stockDNA
Ginkgo Bioworks trades at $9.96, 45.3% below its 52-week high (Oct 6, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +19.9% year to date, −14.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for DNA — after you log in
Open the terminalFrequently asked questions about Ginkgo Bioworks
What is the Ginkgo Bioworks stock price?
At the close on Nov 5, 2026: $9.96 (−14.51% on the day). 52-week high: $18.22 on Oct 6, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Ginkgo Bioworks report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +32% year over year, revenue −59%.
Does Ginkgo Bioworks pay dividends?
No, Ginkgo Bioworks does not pay dividends.
Where does Ginkgo Bioworks trade and how to buy it?
Ticker DNA, exchange NYSE. You can buy it through a broker with access to US exchanges.
Should I buy Ginkgo Bioworks now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for DNA are in the terminal after you log in.